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Abstract
The primary staging of an oesophageal cancer can be difficult, if accompanied by sarcoidosis. In these patients
endosonography, CT and PET may not be sufficient for staging purposes concerning lymph node and distant
metastases. In these special cases operative biopsies of enlarged lymph nodes and unclear pulmonary nodules
have to be obtained. In connection with the radiographic examinations the histopathological results of the biop-
sies contribute to further precise staging and help to decide on a curative versus a palliative therapy concept.
Background
The incidence of sarcoidosis averages 1:10.000 in the
western world [1]. A risk analysis of cancer from
cohorts of Swedish patients with sarcoidosis showed,
that the overall relative risk for cancer development is
increased, especially the risk for cancer of the lung, sto-
mach, small intestine, liver and skin [2]. The coinci-
dence of sarcoidosis and oesophageal cancer is a rare
event. Up until now five such cases were mentioned in
the international literature [2].
The documented cases describe the limitations of the
possible staging procedures in patients with a thoracic
neoplasia accompanied by sarcoidosis. Moreover, a feasi-
ble approach towards these cases is being proposed.
Case presentation
In the year 2007, 283 patients with an adenocarcinoma
of the gastro oesophageal junction (AEG) or an oeso-
phageal cancer were admitted to our hospital. Two
patients, aged 55 and 66, presented with an oesophageal
cancer, a thoracic lymphadenopathy and sarcoidosis in
their past medical history.
The 55-year-old female patient with an adenocarci-
noma of the cardia was referred to our hospital after
neoadjuvant chemotherapy with cisplatin and 5-FU in
Montenegro for a second opinion concerning the resect-
ability of the tumour. In the past medical history a clini-
cal unapparent sarcoidosis was known for the last ten
years. The actual CT scan, the endoscopy and the
endosonography showed an extensive tumour growth
involving the oesophago-gastric junction and enlarged
paraoesophageal, perihilar and paratracheal lymph
nodes. Multiple small disseminated lesions of the lungs
were unchanged compared to the initial CT scan half a
year before (Figure 1 and 2). The parenchymal abdom-
inal organs did not show any metastases.
Since CT scan and FDG PET could not differentiate
between oesophageal metastases and sarcoidosis of the
lungs and the lymph nodes, a mediastinoscopy was per-
formed for further information. Biopsies of the peritra-
cheal lymph nodes showed a granulomatous
inflammation with necrosis, consistent with sarcoidosis.
Thus an oesophagectomy and a reconstruction with a
gastric tube were performed. The histopathological
examination showed a complete resection of the cardia
cancer with 13 positive locoregional lymph nodes.
(UICC-Classification pT3 N2 (13/68) M0 R0 G3). The
sarcoidosis could be diagnosed in the resected mediast-
inal, perihilar and truncular lymph nodes. The patient
was discharged 17 days after resection.
The second patient, a 66-year old woman with sarcoi-
dosis in the past medical history and a squamous cell
cancer of the oesophagus, showed an oesophageal can-
cer with enlarged paraoesophageal and cervical lymph
nodes on CT scan. For further differentiation between
sarcoidosis and lymph node metastasis again mediasti-
noscopy was performed. Histology showed sarcoidosis of
the mediastinal and cervical lymph nodes. Because dis-
tant metastases could be ruled out a neoadjuvant radio-
chemotherapy was performed. The pathologic specimen
after transthoracic oesophagectomy showed a good
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fication ypT3 N1(2/17) M0R0 G3). The resected lymph
nodes in the upper mediastinum showed a granuloma-
tous inflammation consistent with sarcoidosis. Both
patients participate in our follow-up program for two
and a half years already.
Conclusions
The relative risk for malignant disease in patients with
sarcoidosis is increased. Currently two explanations for
this phenomenon are discussed in the literature. In
patients with a history of sarcoidosis chronic inflamma-
tion was suggested to be the putative mediator for the
increased cancer risk [2]. In patients with sarcoid like
lesions occurring in the draining lymph nodes of
tumours after chemo- or radiotherapy the aetiology of
the sarcoid reactions is postulated to be an induced T-
cell-mediated host response to soluble antigenic tumour
factors. The antigenic factors may be either shed by the
tumour cells or released during tumour necrosis [2,3].
Figure 1 CT scan showing a circular oesophageal cancer (1.) with paraoesophageal lymph node involvement (2.) and small sarcoid
lesions of the lung (3.).
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before oesophageal cancer was diagnosed, which makes
the first of the two hypothesis more possible in these
specific cases.
Oesophageal cancer with distant metastases should be
treated in a palliative concept without tumour resection.
Therefore, the differential diagnosis of distant enlarged
lymph nodes (M1a (lymph)) and unclear pulmonary
nodules are crucial for the further treatment.
However, the preoperative staging examinations with
endoscopy, endosonography, CT- and PET scan is lim-
ited and can differ from the postoperative histopatholo-
gical examination [4]. The dilemma of lymph node
diagnosis becomes a specific problem in patients with a
previous history of sarcoidosis [5,6]. Even with an addi-
tional mediastinoscopy the problem cannot completely
be solved since specific lymph node diagnostic can only
be done for a small subset of lymph nodes. By including
Figure 2 Endoscopy and endosonography of the oesophageal tumor with infiltration of all mucosal layers (1) and peritumoral lymph
nodes (2).
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therapy may help in distinguishing sarcoid like lymph
nodes from true metastatic nodes. However, only the
postoperative histological examination of the resected
specimen can give a precise staging like in our patients.
As FDG-PET and CT scan is used extensively in
oncology, clinicians should be aware of sarcoidosis,
which can have the same appearance as diffuse metas-
tases. In patients under otherwise good healthy condi-
tions, who could be treated aggressively with a
neoadjuvant therapy followed by resection of the
tumour in curative intention, pathological diagnosis for
exact pretherapeutic staging should be obtained.
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